PMID: 6112981Jan 1, 1981Paper

Calcium antagonists: definition and mode of action

Basic Research in Cardiology
W G Nayler, P Poole-Wilson

Abstract

The term "calcium antagonist" has been used for more than a decade to describe a group of drugs whose negative inotropism is overcome by calcium. Because this term lacks specificity with respect to a precise mode of action, and implies a classical receptor-agonist-antagonist relationship, its continued use should be questioned. Drugs belonging to this group are verapamil, D600, nifedipine and diltiazem. They inhibit the slow inward current of the action potential and would more appropriately be called "slow channel inhibitors". The group is heterogenous and may have to be subclassified. The negative inotropism of these drugs can be attributed to a reduction of the slow calcium current. The function of most intracellular organelles is unaffected. Studies with radioactively labelled verapamil show tight binding to glycolipids or glycoproteins in the sarcolemma. Consequent change in the conformational state of the cell membrane could inhibit the slow calcium current. The ability of these drugs to protect heart muscle against the deleterious effects of ischaemia and reperfusion may reflect their negative inotropism, with consequent maintenance of tissue ATP above the levels needed to maintain intracellular Ca2+ homeostasis, rather ...Continue Reading

References

Nov 1, 1977·The Journal of General Physiology·J L Kenyon, W R Gibbons
Jan 1, 1977·Annual Review of Pharmacology and Toxicology·A Fleckenstein
Jul 1, 1979·Journal of Molecular and Cellular Cardiology·W G NaylerA Williams
Feb 1, 1977·Circulation Research·A Fabiato, F Fabiato
Jun 1, 1979·The American Journal of Cardiology·R WeishaarR J Bing
Oct 22, 1979·The American Journal of Cardiology·R E ClarkB E Sobel
Oct 22, 1979·The American Journal of Cardiology·M KaltenbachG Kober
Sep 1, 1978·Circulation Research·P D HenryB E Sobel
Oct 1, 1978·Journal of Molecular and Cellular Cardiology·C GuarnieriW G Nayler
Nov 1, 1978·Journal of Molecular and Cellular Cardiology·M Kohlhardt, Z Mnich
Jan 1, 1977·The Journal of Physiology·H Reuter, H Scholz
Aug 15, 1976·FEBS Letters·A M KatzW Hasselbach
Nov 1, 1976·Cardiovascular Research·W G NaylerA Slade
Aug 1, 1975·The Journal of General Physiology·R S Kass, R W Tsien
Jun 1, 1976·The American Journal of Cardiology·N Sperelakis, J A Schneider
Jan 1, 1973·Progress in Biophysics and Molecular Biology·H Reuter
Jan 1, 1972·Pflügers Archiv : European journal of physiology·M KohlhardtA Fleckenstein
Jan 22, 1973·Pflügers Archiv : European journal of physiology·M KohlhardtA Fleckenstein
Jan 1, 1969·Pflügers Archiv : European journal of physiology·O RougierE Coraboeuf
Mar 1, 1970·The Journal of Physiology·G W Beeler, H Reuter

❮ Previous
Next ❯

Citations

Sep 1, 1983·Journal of Autonomic Pharmacology·J BouR Massingham
May 1, 1983·Canadian Anaesthetists' Society Journal·B J KraynackJ Gintautas
Feb 1, 1984·British Journal of Clinical Pharmacology·D G WallerS Roath
Aug 17, 1990·Klinische Wochenschrift·R H SchwingerE Erdmann
Jan 1, 1985·Canadian Anaesthetists' Society Journal·B A Britt
Jan 1, 1984·Acta Medica Scandinavica. Supplementum·K E Andersson, E D Högestätt
Dec 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D S Heffez, J V Passonneau
May 1, 1987·Clinical and Experimental Pharmacology & Physiology·J Staszewska-Woolley
Oct 25, 2001·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·T C HuA P Koretsky
Jun 17, 2003·Journal of Cardiovascular Pharmacology and Therapeutics·Manjeet Singh, Harjot K Saini
Nov 22, 2019·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Ekaterina S YastrebovaAndrei V Chernyshev
Aug 30, 1984·The New England Journal of Medicine·G Huszar, F Naftolin
Jan 1, 1984·Acta Academiae Medicinae Wuhan = Wu-han I Hsüeh Yüan Hsüeh Pao·D C FangM X Jiang
Dec 3, 1982·European Journal of Pharmacology·M HolckG Haeusler
May 20, 1983·European Journal of Pharmacology·M J DalyW G Nayler
Nov 8, 1988·European Journal of Pharmacology·A W Herling, M Ljungström
Nov 18, 1985·Life Sciences·M Schramm, R Towart
Apr 21, 1983·Biochimica Et Biophysica Acta·M M HoG Inesi
Apr 1, 1988·American Heart Journal·J Wikman-CoffeltD T Mason
Jan 30, 2008·American Journal of Obstetrics and Gynecology·Audrey T MoynihanJohn J Morrison
Oct 1, 1986·Japanese Journal of Pharmacology·Y AzumaN Takagi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.